This invention relates generally to viral defense, and particularly to topical chemoprotection against viruses.
Corona viruses are a group of related RNA viruses that cause diseases, such as respiratory tract infections, that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS, and COVID-19.
Methods to slow or stop the spread of COVID-19 infection include: wearing masks, social distancing, mRNA vaccination, and/or various drug therapies. Nevertheless, COVID-19 remains a threat, especially as new variants are discovered that appear resistant to the known methods.
The kit of the invention is a ready-to-use kit for protecting two major portals of entry of viruses into the body (the nose and the mouth) using pre-moistened swabs.
Each kit includes at least two pre-moistened nasal swabs and at least one premoistened oral swab. Optionally, pre-moistened alcohol pads are also included for sterilizing the inner surface of a mask to reduce viral and bacterial build-up after using the mask for a period of time.
Wearing a mask and social distancing are known strategies of prevention, which attempt to prevent viruses from entering the nose and the mouth. The kit and method of the invention provide an extra layer of protection against viral entry (in addition to wearing a mask, social distancing, etc.), thereby providing more prevention.
The kit and method of the invention add to those known prevention strategies by using pre-moistened swabs to topically kill viruses that may have entered the mouth and nose, before they gain a foothold in the rest of the body. Further, using pre-moistened alcohol pads to sterilize the inner surface of a mask periodically during use also helps prevent viruses and bacteria from building to dangerous levels on the inner surface of the mask.
A general aspect of the invention is a kit for providing additional defense against Corona Virus strains. The kit includes: at least one nasal swab pre-moistened with an iodine solution; and at least one oral swab pre-moistened with a chlorhexidine solution.
In some embodiments, the iodine solution of the at least one nasal swab is a betadine solution.
In some embodiments, the betadine solution is betadine 0.5-2.0%.
In some embodiments, the iodine solution of the at least one nasal swab is a povidone solution.
In some embodiments, the iodine solution of the at least one nasal swab is replaced with chlorhexidine 0.09% to 0.12%.
In some embodiments, the chlorhexidine solution of the at least one oral swab is chlorhexidine 0.09% to 0.12%.
In some embodiments, the at least one nasal swab pre-moistened with an iodine solution is sealed in a package.
In some embodiments, the package includes a plurality of nasal swabs pre-moistened with an iodine solution, and the package is resealable.
In some embodiments, a pair of nasal swabs pre-moistened with the iodine solution are included in a sealed package.
In some embodiments, the at least one oral swab pre-moistened with a chlorhexidine solution is sealed in a package.
In some embodiments, the package includes a plurality of oral swabs pre-moistened with a chlorhexidine solution, and the package is resealable.
In some embodiments, the kit also includes a plurality of alcohol swabs.
In some embodiments, the alcohol swabs are pre-moistened with 60%-70% Isopropyl Alcohol and are sealed in a disposable package.
In some embodiments, the plurality of alcohol swabs consists of four alcohol swabs.
In some embodiments, each alcohol swab includes a rectangular or square piece of gauze.
In some embodiments, each alcohol swab includes a swab stick.
In some embodiments, each alcohol swab includes a swab made from cotton.
In some embodiments, the at least one nasal swab pre-moistened with an iodine solution is sealed in a sterile package.
In some embodiments, the at least one oral swab pre-moistened with a chlorhexidine solution is sealed in a sterile package.
In some embodiments, the plurality of alcohol swabs are sealed in a sterile package.
Another general aspect of the invention is a method for providing additional defense against Corona Virus strains to a person having a mouth and a nose with two nostrils. The method includes: using at least one nasal swab pre-moistened with an iodine solution to apply the iodine solution to a surface within each of the two nostrils; and using at least one oral swab pre-moistened with a chlorhexidine solution to apply the chlorhexidine solution to a surface within the mouth.
In some embodiments, the iodine solution of the at least one nasal swab is a betadine solution.
In some embodiments, the betadine solution is betadine 0.5-2.0%.
In some embodiments, the iodine solution of the at least one nasal swab is a povidone solution.
In some embodiments, the iodine solution of the at least one nasal swab is replaced with chlorhexidine 0.09% to 0.12%.
In some embodiments, the chlorhexidine solution of the at least one oral swab is chlorhexidine 0.09% to 0.12%.
In some embodiments, the method also includes: before using the at least one nasal swab, removing the at least one nasal swab from a package.
In some embodiments, the method also includes: after removing the at least one nasal swab from the package, resealing the package.
In some embodiments, the method also includes: before using the at least one oral swab, removing the at least one oral swab from a package.
In some embodiments, the method also includes: after removing the at least one oral swab from the package, resealing the package.
Many additional features and advantages will become apparent to those skilled in the art upon reading the following description, when considered in conjunction with the accompanying drawings, wherein:
With reference to
Referring to
With reference to
Referring to
With reference to
Referring to
With reference to
Referring to
With reference to
Referring to
The kit and method of the invention include the use of 4″ long cotton nasal swabs pre-moistened with betadine or povidone iodine solution. A person inserts a nasal swab into each nostril, using one nasal swab per nostril. The nasal swabs are sterile and are pre-moistened with 2% betadine, for example, or povidone iodine solution.
An oral swab that is 6″ long is also included that is pre-moistened in 0.12% chlorhexidine solution, for example. The chlorhexidine can be 0.09% to 0.12%. Usually, 0.12% chlorhexidine solution can be used.
The povidone iodine concentration can be 0.5%, 1.0%, or 2.0%, depending on the level of prevention desired. Usually, 0.5% povidone iodine solution can be used.
If one wants to create a pre-moistened nasal swab, a dry cotton swab can be dipped in 2 ml of 0.5% povidone iodine solution for 15 seconds. If one wants to create a pre-moistened oral swab, a dry cotton swab can be dipped in 15 ml of 0.12% chlorhexidine solution for 15 seconds.
Each of the two nasal swabs is to be pre-moistened in 2 mL of betadine solution, so 4 mL total of betadine solution would be used to pre-moisten two nasal swabs. The minimum number of nasal swabs in a kit is two, and the minimum number or oral swabs in a kit is one.
Optionally, for further protection, alcohol swabs can be used for sterilizing the inner surface of a mask. Four alcohol pads (pre-moistened with 70% alcohol) can optionally be part of the kit.
Other modifications and implementations will occur to those skilled in the art without departing from the spirit and the scope of the invention as claimed. Accordingly, the above description is not intended to limit the invention, except as indicated in the following claims.